Literature DB >> 2907002

Inhibition of acetylcholinesterase by the H2-receptor antagonist nizatidine.

G Kounenis1, D Voutsas, M Koutsoviti-Papadopoulou, V Elezoglou.   

Abstract

The purpose of the present investigation was to study if the stimulating effect of nizatidine on the intestinal smooth muscle is related to the acetylcholinesterase activity. Isolated segments of guinea pig ileum were used in Tyrode solution at 37 degrees C. Nizatidine (from 3.2 x 10(-6) to 3.2 x 10(-4) M) exerted a concentration-dependent contractile effect on the guinea pig ileum. The average maximum activity (mean +/- S.E.M.) of nizatidine (3.2 x 10(-4) M) was 96.21 +/- 6.19% of the average maximum activity of neostigmine (3.2 x 10(-6) M). The acetylcholine-induced contractions (from 10(-8) to 3.2 x 10(-6) M) were augmented by nizatidine (from 10(-5) to 10(-4) M) in a similar way to that by neostigmine (from 10(-8) to 10(-7) M). The acetylcholine-induced contractions were prevented by acetylcholinesterase (0.1 unit/ml). This acetylcholinesterase activity was inhibited by nizatidine (from 10(-5) to 10(-4) M) and this inhibition was similar to that of neostigmine (from 10(-8) to 10(-7) M). These findings suggest that the stimulating effect of nizatidine on the intestinal smooth muscle of the guinea pig ileum could be explained by the inhibition of acetycholinesterase activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907002     DOI: 10.1248/bpb1978.11.767

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  7 in total

1.  Stimulation by nizatidine, a histamine H(2)-receptor antagonist, of duodenal HCO(3)(-)secretion in rats:relation to anti-cholinesterase activity.

Authors:  Koji Takeuchi; Shoji Kawauchi; Hideo Araki; Shigeru Ueki; Osamu Furukawa
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine.

Authors:  Tomohiko Shimatani; Masaki Inoue; Tomoko Kuroiwa; Jing Xu; Masuo Nakamura; Susumu Tazuma; Kazuro Ikawa; Norifumi Morikawa
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

3.  Nizatidine accelerates gastric emptying of a solid meal in rats.

Authors:  H Kaneko; T Mitsuma; K Uchida; H Nagai; M Harada; H Kotera
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

4.  Nizatidine and cisapride increase salivary secretion in rats.

Authors:  Kyoichi Adachi; Kenji Furuta; Tomoko Katsube; Tomoo Fujisawa; Takane Azumi; Hirofumi Fujishiro; Shunji Ishihara; Yuji Amano; Yoshikazu Kinoshita
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

5.  A study of the effects of saliva stimulation by nizatidine on dry mouth symptoms of primary biliary cirrhosis.

Authors:  Tetsu Kikuchi; Katsuharu Hirano; Takuya Genda; Hironori Tsuzura; Shunsuke Sato; Yoshio Kanemitsu; Yutaka Narita; Katsuyori Iijima; Takafumi Ichida
Journal:  World J Hepatol       Date:  2013-03-27

6.  Rebamipide and mosapride enhance pilocarpine-induced salivation.

Authors:  Yoshihisa Urita; Toshiyasu Watanabe; Tadashi Maeda; Yosuke Sasaki; Kazuo Hike; Hiroshi Muto; Masaki Sanaka; Nagato Shimada; Hitoshi Nakajima; Motonobu Sugimoto
Journal:  N Am J Med Sci       Date:  2009-08

7.  Nizatidine Improves Impaired Salivary Secretion in GERD.

Authors:  Yoshihisa Urita; Toshiyasu Watanabe; Kazuo Hike; Makie Nanami; Tadashi Maeda; Yosuke Sasaki; Asuka Nakayama; Takamasa Ishii; Kaoru Domon; Susumu Ishihara; Masaki Sanaka; Hitoshi Nakajima; Motonobu Sugimoto
Journal:  Clin Med Case Rep       Date:  2008-08-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.